Megan Chacon, a principal at Fish & Richardson and a member of the firm’s life sciences industry team, answers questions ...

Imagine a gem hunter facing a vast and uncharted landscape to uncover a single beautiful diamond. It is a bit like drug discovery. Scientists create and evaluate hundreds and thousands of molecules in ...

A panel of biopharmaceutical leaders convened at the Galien Forum discussed the impacts of the Inflation Reduction Act so far ...

InflaRx cofounder and CEO Niels Riedemann, M.D. shares the overarching pillars that have shaped his career as a physician, ...

With just the click of a button on your smartphone, you can order virtually anything and have it on your doorstep in one or ...

In the world of biopharmaceutical innovation, groundbreaking scientific discoveries often do not directly translate into commercial success. Simply developing a promising therapeutic based on great ...

No drug is free from risks, and no two human anatomies are completely identical (meaning different individuals can face different risks), but from a real-world patient perspective — anecdotally — the ...

Even in the best funding environments, raising money for drug discovery is an enormous challenge. It takes about 10 years and upwards of a billion dollars to move a drug candidate from the lab through ...

Then: In 2016, when former Life Science Leader editor Rob Wright wrote about cofounder Peter Hecht and Ironwood Pharmaceuticals, the company was ascending. After its initial launch in 1998, the ...